Diagnostic ability of B-type natriuretic peptide and impedance cardiography: Testing to identify left ventricular dysfunction in hypertensive patients

American Journal of Hypertension

Volumn 18, Issue 2 SUPPL., 2005, Pages 73-81

  Bhalla, Vikas ^a   Isakson, Susan ^a   Bhalla, Meenakshi A ^a   Lin, Jeannette P ^a   Clopton, Paul ^a   Gardetto, Nancy ^a   Maisel, Alan S ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

B type natriuretic peptide (BNP); Echocardiography; Hypertension; Impedance cardiography; Ventricular dysfunction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANGINA PECTORIS; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART INDEX; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART WORK; HIGH RISK POPULATION; HUMAN; HYPERTENSION; IMPEDANCE CARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROC CURVE; SYMPTOM; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; VALVULAR HEART DISEASE;

EID: 14744304438     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.11.044     Document Type: Article

References (29)

1. D.K. Cherry, D.A. Woodwell National Ambulatory Medical Care Survey. 2000 Summary Advance Data 328 2002 1 32
2. A. Ganau, R.B. Devereux, M.J. Roman, G. de Simone, T.G. Pickering, P.S. Saba, P. Vargiu, I. Simongini, J.H. Laragh Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension J Am Coll Cardiol 19 1992 1550 1558
3. B. Neal, S. MacMahon, N. Chapman Blood Pressure Lowering Treatment Trialists' Collaboration Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration Lancet 356 2000 1955 1964
4. L.G. Ogden, J. He, E. Lydick, P.K. Whelton Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification Hypertension 35 2000 539 543
5. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo, D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright, E.J. Roccella The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report J Am Med Assoc 289 2003 2560 2572
6. R.B. Devereux, P.R. Liebson, M.J. Horan Recommendations concerning use of echocardiography in hypertension and general population research Hypertension 9 1987 II97 II104
7. A.S. Maisel, J. Koon, P. Krishnaswamy, R. Kazenegra, P. Clopton, N. Gardetto, R. Morrisey, A. Garcia, A. Chiu, A. De Maria Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction Am Heart J 141 2001 367 374
8. P. Krishnaswamy, E. Lubein, P. Clopton, J. Koon, R. Kazanegra, E. Wanner, N. Gardetto, A. Garcia, A. DeMaria, A.S. Maisel Utility of B-type natriuretic peptide (BNP) in elucidating left ventricular dysfunction (systolic and diastolic) in patients with and without symptoms of congestive heart failure at a Veterans Hospital Am J Med 111 2001 274 279
9. B. Thompson, M.H. Drazner, D.L. Dries, C.W. Yancy Is impedance cardiography-derived systolic time ratio a useful method to determine left ventricular systolic dysfunction in heart failure? J Card Fail 10 Suppl 2004 S38
10. C. Parrott, K. Burnham, C. Quale, D. Lewis Comparison of changes in ejection fraction to changes in impedance cardiography cardiac index and systolic time ratio Congest Heart Fail 10 Suppl 2 2004 11 13
11. P. Krishnaswamy, E. Lubien, P. Clopton, J. Koon, R. Kazanegra, E. Wanner, N. Gardetto, A. Garcia, A. DeMaria, A.S. Maisel Utility of B-type natriuretic peptide (BNP) in elucidating left ventricular dysfunction (systolic and diastolic) in patients with and without symptoms of congestive heart failure at a veterans hospital Am J Med 111 2001 274 279
12. E. Lubien, A. DeMaria, P. Krishnaswamy, P. Clopton, J. Koon, R. Kazanegra, N. Gardetto, E. Wanner, A.S. Maisel Utility of B-natriuretic peptide in detecting diastolic dysfunction comparison with Doppler velocity recordings Circulation 105 2002 595 601
13. C. Yancy, W. Abraham Noninvasive hemodynamic monitoring in heart failure utilization of impedance cardiography Congest Heart Fail 9 2003 241 250
14. Q. Dao, P. Krishnaswamy, R. Kazanegra, A. Harrison, R. Amirnovin, L. Lenert, P. Clopton, J. Alberto, P. Hlavin, A.S. Maisel Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting J Am Coll Cardiol 37 2001 379 385
15. K.F. Fox, M.R. Cowie, D.A. Wood The etiological importance of coronary artery disease in new cases of heart failure Eur Heart J 22 2001 228 236
16. J. Remes, H. Miettinen, A. Reunanen, K. Pyorala Validity of clinical diagnosis of heart failure in primary health care Eur Heart J 12 1991 315 321
17. N. van Royen, C.C. Jaffe, H.M. Krumholz, K.M. Johnson, P.J. Lynch, D. Natale, P. Atkinson, P. Deman, F.J. Wackers Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions Am J Cardiol 77 1996 843 850
18. M. Packer How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease Am J Cardiol 71 1993 3C 11C
19. V. Cheng, R. Kazanegra, A. Garcia, L. Lenert, P. Krishnaswamy, N. Gardetto, P. Clopton, A. Maisel A rapid bedside test for peptide (BNP) predicts treatment outcomes in patients admitted for decompensated heart failure J Am Coll Cardiol 37 2001 386 391
20. A.S. Maisel, J. Koon, P. Krishnaswamy, R. Kazenegra, P. Clopton, N. Gardetto, R. Morrisey, A. Garcia, A. Chiu, A. De Maria Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction Am Heart J 141 2001 367 374
21. C. Springfield, F. Sebat, D. Johnson, S. Lengle, C. Sebat Utility of impedance cardiography to determine cardiac vs. noncardiac cause of dyspnea in the emergency department Congest Heart Fail 10 Suppl 2 2004 14 16
22. F. Peacock, R. Summers, C. Emerman Emergent dyspnea impedance cardiography-aided assessment changes therapy the ED IMPACT trial J Card Fail 10 Suppl 2004 S119
23. W.T. Abraham, R.J. Trupp, M.R. Mehra, C.E. Lawless, J.E. Mitchell, T.H. Le Jemtel, F.W. Smart, R. Bijou, C.M. O'Connor, C.W. Yancy, B.M. Massie, M.A. Silver, M. Packer A multivariate impedance cardiography composite score can predict the occurrence of major heart failure events Circulation 110 Suppl 3 2004 597
24. E. Barcarse, R. Kazanegra, A. Chen, A. Chiu, P. Clopton, A. Maisel Combination of B-type natriuretic peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department Congest Heart Fail 10 2004 171 176
25. A. Zewail, C. Broom, R. Delgado Use of systolic time ratio and B-type natriuretic peptide to predict mortality in patients with heart failure J Card Fail 9 Suppl 2003 S105
26. D. Atisha, M.A. Bhalla, L.K. Morrison, L. Felicio, P. Clopton, N. Gardetto, R. Kazanegra, A. Chiu, A.S. Maisel A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction Am Heart J 148 2004 518 523
27. R.H. Fagard, K. Pardaens, J.A. Staessen, L. Thijs Prognostic value of invasive hemodynamic measurements at rest and during exercise in hypertensive men Hypertension 28 1996 31 36
28. R.H. Fagard, K. Pardaens, J.A. Staessen, L. Thijs The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension J Am Coll Cardiol 38 2001 227 231
29. G. de Simone, M.J. Roman, M.J. Koren, G.A. Mensah, A. Ganau, R.B. Devereux Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension Hypertens 33 1999 800 805